Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
Phase 2b, randomized, double-blind 12-week studies of TZP-102, a ghrelin receptor agonist for diabetic gastroparesis. [electronic resource] by
- McCallum, R W
- Lembo, A
- Esfandyari, T
- Bhandari, B R
- Ejskjaer, N
- Cosentino, C
- Helton, N
- Mondou, E
- Quinn, J
- Rousseau, F
Producer: 20140813
In:
Neurogastroenterology and motility vol. 25
Availability: No items available.
|
|
7.
|
A phase 2a, randomized, double-blind 28-day study of TZP-102 a ghrelin receptor agonist for diabetic gastroparesis. [electronic resource] by
- Ejskjaer, N
- Wo, J M
- Esfandyari, T
- Mazen Jamal, M
- Dimcevski, G
- Tarnow, L
- Malik, R A
- Hellström, P M
- Mondou, E
- Quinn, J
- Rousseau, F
- McCallum, R W
Producer: 20130910
In:
Neurogastroenterology and motility vol. 25
Availability: No items available.
|
|
8.
|
Dose range study of pharmacokinetics, safety, and preliminary antiviral activity of emtricitabine in adults with hepatitis B virus infection. [electronic resource] by
- Gish, R G
- Leung, N W Y
- Wright, T L
- Trinh, Huy
- Lang, W
- Kessler, H A
- Fang, L
- Wang, L H
- Delehanty, J
- Rigney, A
- Mondou, E
- Snow, A
- Rousseau, F
Producer: 20021022
In:
Antimicrobial agents and chemotherapy vol. 46
Availability: No items available.
|